These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 9058379)

  • 21. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.
    Lu D; Kiriyama Y; Lee KY; Giguère V
    Cancer Res; 2001 Sep; 61(18):6755-61. PubMed ID: 11559547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen-induced retinoic acid receptor alpha 1 gene expression: role of estrogen receptor-Sp1 complex.
    Sun G; Porter W; Safe S
    Mol Endocrinol; 1998 Jun; 12(6):882-90. PubMed ID: 9626663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of an estrogen-responsive element in the rat LH beta gene. DNA-estrogen receptor interactions and functional analysis.
    Shupnik MA; Rosenzweig BA
    J Biol Chem; 1991 Sep; 266(26):17084-91. PubMed ID: 1894604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
    Luo LY; Grass L; Diamandis EP
    Clin Chim Acta; 2003 Nov; 337(1-2):115-26. PubMed ID: 14568187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes.
    Krieg AJ; Krieg SA; Ahn BS; Shapiro DJ
    J Biol Chem; 2004 Feb; 279(6):5025-34. PubMed ID: 14617632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms.
    Demirpence E; Balaguer P; Trousse F; Nicolas JC; Pons M; Gagne D
    Cancer Res; 1994 Mar; 54(6):1458-64. PubMed ID: 8137248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor.
    Migliaccio S; Davis VL; Gibson MK; Gray TK; Korach KS
    Endocrinology; 1992 May; 130(5):2617-24. PubMed ID: 1572285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells.
    Zhang CC; Krieg S; Shapiro DJ
    Mol Endocrinol; 1999 Apr; 13(4):632-43. PubMed ID: 10194768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen regulation of chicken riboflavin carrier protein gene is mediated by ERE half sites without direct binding of estrogen receptor.
    Bahadur U; Ganjam GK; Vasudevan N; Kondaiah P
    Mol Cell Endocrinol; 2005 Feb; 231(1-2):1-11. PubMed ID: 15713531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The promoter of the rat 3-hydroxy-3-methylglutaryl coenzyme A reductase gene contains a tissue-specific estrogen-responsive region.
    Di Croce L; Vicent GP; Pecci A; Bruscalupi G; Trentalance A; Beato M
    Mol Endocrinol; 1999 Aug; 13(8):1225-36. PubMed ID: 10446899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression.
    Porter W; Wang F; Wang W; Duan R; Safe S
    Mol Endocrinol; 1996 Nov; 10(11):1371-8. PubMed ID: 8923463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
    Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
    Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.
    Jeng MH; Langan-Fahey SM; Jordan VC
    Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A histone deacetylase inhibitor potentiates estrogen receptor activation of a stably integrated vitellogenin promoter in HepG2 cells.
    Mao C; Shapiro DJ
    Endocrinology; 2000 Jul; 141(7):2361-9. PubMed ID: 10875235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allosteric modulation of estrogen receptor conformation by different estrogen response elements.
    Wood JR; Likhite VS; Loven MA; Nardulli AM
    Mol Endocrinol; 2001 Jul; 15(7):1114-26. PubMed ID: 11435612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum.
    Moore M; Mustain M; Daniel K; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):160-8. PubMed ID: 9007045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation by estrogen through the 5'-flanking region of the mouse calbindin-D28k gene.
    Gill RK; Christakos S
    Mol Endocrinol; 1995 Mar; 9(3):319-26. PubMed ID: 7776978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
    Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
    Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.